Search Results - "BAILEN, A"

Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response by Sanchez-Garcia, J, Hernandez-Sanchez, J.M, Falantes, J, Benito, R, Medina, A, Lumbreras, E, Hernandez-Mohedo, F, Hermosin, L, Bailen, A, Maria, S, Casaño, J, Calderon, C, Labrador-Mateo, M, Serrano, J, Hernandez-Rivas, J.M

Get full text

A Free New Dietary Supplement Label Database for Registered Dietitian Nutritionists by Dwyer, Johanna T., DSc, RD, Saldanha, Leila G., PhD, RD, Bailen, Richard A., MHA, MBA, Bailey, Regan L., PhD, RD, Costello, Rebecca B., PhD, Betz, Joseph M., PhD, Chang, Florence F., MS, Goshorn, Jeanne, MS, Andrews, Karen W, Pehrsson, Pamela R., PhD, Milner, John A., PhD, Burt, Vicki L., MSc RN, Gahche, Jaime J., MPH, Hardy, Constance J., MS, Emenaker, Nancy J., PhD, RD

Get full text

114 FINAL RESULTS OF PHASE II RANDOMIZED TRIAL OF AZACITIDINE VERSUS SUPPORT TREATMENT IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME WITHOUT THE 5Q DELETION by Sanchez-Garcia, J, Falantes, J, Medina, A, Hernandez-Mohedo, F, Torres-Sabariego, A, Bailen, A, Sole, M, Casaño, J, Calderon, C, Hermosin, L, Vahi, M, Serrano, J

Get full text

Modernization of the National Institutes of Health Dietary Supplement Label Database by Saldanha, Leila G., Dwyer, Johanna T., Bailen, Richard A.

“…•The technological updates will make it easier to navigate the DSLD, which contains over 125,000 (current and historic) product labels.•The DSLD features a…”
Get full text

P-311 Interim analysis of phase II randomized trial of azacitidine versus support treatment in patients with low-risk myelodysplastic syndrome by Sanchez-Garcia, J, Falantes, J, Medina, A, Hernandez-Mohedo, F, Torres-Sabariego, A, Hermosin, L, Bailen, A, Sole, M, Casaño, J, Calderon, C, Vahi, M, Serrano, J

Get full text

Do Multivitamin/Mineral Dietary Supplements for Young Children Fill Critical Nutrient Gaps? by Dwyer, Johanna T., Saldanha, Leila G., Bailen, Richard A., Gahche, Jaime J., Potischman, Nancy, Bailey, Regan L., Jun, Shinyoung, Long, Yue, Connor, Emily, Andrews, Karen W., Pehrsson, Pamela R., Gusev, Pavel A.

“…Nearly a third of young US children take multivitamin/mineral (MVM) dietary supplements, yet it is unclear how formulations compare with requirements. Describe…”
Get full text

Direct synthesis of hydroxamates from carboxylic acids using 2-mercaptopyridone-1-oxide-based thiouronium salts by Bailén, Miguel A, Chinchilla, Rafael, Dodsworth, David J, Nájera, Carmen

Get full text

Characteristics and Challenges of Dietary Supplement Databases Derived from Label Information by Saldanha, Leila G, Dwyer, Johanna T, Bailen, Richard A, Andrews, Karen W, Betz, Joseph W, Chang, Hua F, Costello, Rebecca B, Ershow, Abby G, Goshorn, Jeanne, Hardy, Constance J, Coates, Paul M

“…Launched in 2008, the Dietary Supplement Label Database (DSLD) permits the search of any term that appears anywhere on product labels. Since then, the…”
Get more information

The Dietary Supplement Label Database: Recent Developments and Applications by Dwyer, Johanna T, Bailen, Richard A, Saldanha, Leila G, Gahche, Jaime J, Costello, Rebecca B, Betz, Joseph M, Davis, Cindy D, Bailey, Regan L, Potischman, Nancy, Ershow, Abby G, Sorkin, Barbara C, Kuszak, Adam J, Rios-Avila, Luisa, Chang, Florence, Goshorn, Jeanne, Andrews, Karen W, Pehrsson, Pamela R, Gusev, Pavel A, Harnly, James M, Hardy, Constance J, Emenaker, Nancy J, Herrick, Kirsten A

“…To describe the history, key features, recent enhancements, and common applications of the Dietary Supplement Label Database (DSLD). Although many Americans…”
Get more information

261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS by Calvo, X, Arenillas, L, Tormo, M.C, Valcárcel, D, Luño, E, Alonso, E, Díez-Campelo, M, Ramos, F, Pedro, C, Arrizabalaga, B, Bailen, A, Raya, J.M, Ardanaz, M.T, Sanz, G.F, Florensa, L

Get full text

64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion by Sanchez-Garcia, J, Del Cañizo, C, Such, E, Nomdedeu, B, Luño, E, De Paz, R, Xicoy, B, Valcarcel, D, Sierra, A, Marco, V, Garcia, M, Osorio, S, Tormo, M, Bailen, A, Cervero, C, Torres-Gomez, A, Ramos, F, Diez-Campelo, M, Belkaid, M, Arrizabalaga, B, Azaceta, G, Bargay, J, Arilla, M.J, Caballero, M, Falantes, J, Sanz, G

Get full text

Efficient synthesis of primary amides using 2-mercaptopyridone-1-oxide-based uronium salts by Bailén, Miguel A., Chinchilla, Rafael, Dodsworth, David J., Nájera, Carmen

“…S-(1-Oxido-2-pyridinyl)-1,1,3,3-tetramethylthiouronium tetrafluoroborate (TOTT) and hexafluorophosphate (HOTT) are cheap and convenient reagents for the rapid…”
Get full text

P-565 Pharmacogenetic (PGx) Gene-Drug Association in IVF: clinical relevance of a panel test for ovarian stimulation by Lledo, B, Ortiz, J.A, Iervolino, N, Bailen, A, Morales, R, Castillo, J.C, Bernabeu, A, Bernabeu, R

“…Abstract Study question Could the PGx approach be useful for increasing the number of mature oocytes after personalized COS? Summary answer There was an…”
Get full text

Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients by Díez Campelo, M, Sánchez-Barba, M, de Soria, V. Gómez-García, Martino, R, Sanz, G, Insunza, A, Bernal, T, Duarte, R, Amigo, M.L, Xicoy, B, Tormo, M, Iniesta, F, Bailén, A, Benlloch, L, Córdoba, I, López-Villar, O, del Cañizo, M.C

“…Abstract Although new agents have been approved for the treatment of MDS, the only curative approach is allogeneic hematopoietic stem cell transplantation…”
Get full text

2-Mercaptopyridone 1-Oxide-Based Uronium Salts: New Peptide Coupling Reagents(1)(,)(2) by Bailén, Miguel A., Chinchilla, Rafael, Dodsworth, David J., Nájera, Carmen

Get full text

Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study by SOLANO, C, MARTINEZ, C, SIERRA, J, GARCIA-CONDE, J, ROZMAN, C, BRUNET, S, TOMAS, J. F, URBANO-ISPIZUA, A, ZUAZU, J, OJEDA, E, BARGAY, J, MORALEDA, J. M, BAILEN, A

“…We retrospectively compared the incidence and clinical characteristics of cGVHD in 37 allo-PBT recipients transplanted between July 1994 and October 1996 and…”
Get full text

2-Mercaptopyridine-1-oxide-based peptide coupling reagents by Albericio, Fernando, Bailén, Miguel A, Chinchilla, Rafael, Dodsworth, David J, Nájera, Carmen

“…The thiouronium salts S-(1-oxido-2-pyridinyl)-1,1,3,3-tetramethylthiouronium hexafluorophosphate (HOTT) and tetrafluoroborate (TOTT), and…”
Get full text

O-Succinimidyl-1,3-dimethyl-1,3-trimethyleneuronium salts as efficient reagents in active ester synthesis by Bailén, Miguel A, Chinchilla, Rafael, Dodsworth, David J, Nájera, Carmen

“…The new uronium salts O-succinimidyl-1,3-dimethyl-1,3-trimethyleneuronium hexafluorophosphate (HSDU) and tetrafluoroborate (TSDU) have been prepared from…”
Get full text

260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS by Arenillas, L, Calvo, X, Tormo, M, Valcárcel, D, Luño, E, Alonso, E, Cañizo, M.C, Ramos, F, Pedro, C, Arrizabalaga, B, Bailén, A, Raya, J.M, Ardanaz, M.T, Sanz, G.F, Florensa, L

Get full text

Posttransplant Lymphoproliferative Disease: A Series of 23 Cases by Martín-Gómez, M.A., Peña, M., Cabello, M., Burgos, D., Gutierrez, C., Sola, E., Acedo, C., Bailén, A., Gonzalez-Molina, M.

“…Posttransplant lymphoproliferative disease (PTLD) is a rare but clinically important disorder due to its increasing incidence and its impact on renal function…”
Get full text